Apnimed, Inc. (APMD)

27.33 -1.67 (-5.76%) USD  |  NASDAQ  |  Sep 21, 09:56
More

Apnimed EPS Diluted (Quarterly) : 3.025 for June 30, 2026

EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for APMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2025. Start Trial.
Date Value
June 30, 2026 3.025
March 31, 2026 1.700
Date Value
June 30, 2025 -1.669
March 31, 2025 -0.7193

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
IGC Pharma, Inc. -0.0293
Cocrystal Pharma, Inc. -0.2295
CNBX Pharmaceuticals, Inc. -0.0001
GB Sciences, Inc. --
Arvinas, Inc. 2.578

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) 126.11M
Revenue (Quarterly) 12.08M
Total Expenses (Quarterly) -114.03M
Enterprise Value 1.361B
Gross Profit Margin (Quarterly) 89.98%
Earnings Yield 8.55%
Operating Earnings Yield 2.09%
Normalized Earnings Yield 8.666